This announcement is a separate document:
奥翔药业：奥翔药业2022年半年度报告摘要
Aoxiang Pharmaceutical: Summary of Aoxiang Pharmaceutical's 2022 Semi-Annual Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.